Zaloguj się

Gotowe bibliografie tematyczne / Biochemical markers / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Biochemical markers.

Artykuły w czasopismach na temat „Biochemical markers”

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 1 sierpnia 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Biochemical markers”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Ahmed, Mohamed H. "Biochemical Markers". American Journal of Clinical Pathology 127, nr 1 (styczeń 2007): 20–22. http://dx.doi.org/10.1309/jxwum661t8vt1etx.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Rothstein, Jeffrey. "Biochemical markers: Pro". Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (wrzesień 2002): S81. http://dx.doi.org/10.1080/146608202320374381.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Mitsumoto, Hiroshi. "Biochemical markers: Con". Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (wrzesień 2002): S83. http://dx.doi.org/10.1080/146608202320374390.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Strong, Michael J. "Biochemical markers: Summary". Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (wrzesień 2002): S85—S90. http://dx.doi.org/10.1080/146608202320374408.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Sandberg, Dr K. "3. Biochemical markers". Animal Genetics 20, nr 1 (24.04.2009): 56–83. http://dx.doi.org/10.1111/j.1365-2052.1989.tb01910.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Seishima, Mitsuru, Makiko Suzuki i Satoshi Maeda. "Atherosclerosis and biochemical markers." SEIBUTSU BUTSURI KAGAKU 48, nr 4 (2004): 143–46. http://dx.doi.org/10.2198/sbk.48.143.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Selroos, Olof B. N. "Biochemical Markers in Sarcoidosis". CRC Critical Reviews in Clinical Laboratory Sciences 24, nr 3 (styczeń 1986): 185–216. http://dx.doi.org/10.3109/10408368609110273.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Đerić, Mirjana, Sunčica Kojić-Damjanov, Velibor Čabarkapa i Nevena Eremić. "Biochemical Markers of Atherosclerosis". Journal of Medical Biochemistry 27, nr 2 (1.01.2008): 148–53. http://dx.doi.org/10.2478/v10011-008-0008-1.

Pełny tekst źródła

Streszczenie:

Biochemical Markers of AtherosclerosisThis paper is a brief review of some lipid parameters and serum markers of inflammation in a view of their predictive relevance for the atherosclerotic disease. A discourse on the importance of measuring different lipids and lipoproteins, concentration of LDL particles and apolipoprotein levels is still underway. Also, the recommendations for apolipoprotein (a), phenotypization and other lipid markers have not yet been established. In recent years the recommendations imply simultaneous measuring of multiple markers and calculating the lipid index values such as lipid tetrad index (LTI), lipid pentad index (LPI) and atherogenic index of plasma (AIP). Several circulating markers of inflammation such as C-reactive protein, serum fibrinogen and elevated leukocyte number, are consistently associated with atherosclerosis. In spite of a lack of evidence on measuring the C-reactive protein in a wide population, the guidelines for its application in diagnostics and therapy of coronary heart disease were developed. Some proinflammatory cytokines, adhesion molecules and markers of leukocyte activation are promising markers, requiring, however, more detailed prospective evaluation. The question to be elucidated is if these inflammatory markers are directly involved in the pathogenic process.

Style APA, Harvard, Vancouver, ISO itp.

9

Kanis, John. "Biochemical markers in osteoporosis". Scandinavian Journal of Clinical and Laboratory Investigation 57 (1997): 6–11. http://dx.doi.org/10.3109/00365519709168303.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Ratcliffe, Anthony, i Markus J. Seibel. "Biochemical markers of osteoarthritis". Current Opinion in Rheumatology 2, nr 5 (październik 1990): 770–76. http://dx.doi.org/10.1097/00002281-199002050-00014.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Kanis, John A. "Biochemical markers in osteoporosis". Scandinavian Journal of Clinical and Laboratory Investigation 57, sup227 (styczeń 1997): 6–11. http://dx.doi.org/10.1080/00365519709168303.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Jung, Rex E., Ronald A. Yeo, Stephen J. Chiulli, Wilmer L. Sibbitt, David C. Weers, Blaine L. Hart i William M. Brooks. "Biochemical markers of cognition". NeuroReport 10, nr 16 (listopad 1999): 3327–31. http://dx.doi.org/10.1097/00001756-199911080-00014.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Ikizler, T. Alp. "Biochemical markers: Clinical aspects". Journal of Renal Nutrition 7, nr 2 (kwiecień 1997): 61–64. http://dx.doi.org/10.1016/s1051-2276(97)90039-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Paselk, R. "Biochemical Markers for Cancer". Biochemical Education 13, nr 1 (styczeń 1985): 43. http://dx.doi.org/10.1016/0307-4412(85)90154-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Stadtman, E. R. "Biochemical markers of aging". Experimental Gerontology 23, nr 4-5 (styczeń 1988): 327–47. http://dx.doi.org/10.1016/0531-5565(88)90036-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Samoilova, I. G., M. V. Matveeva i D. E. Galyukova. "Biochemical markers of autism". Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 124, nr 1 (2024): 55. http://dx.doi.org/10.17116/jnevro202412401155.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Duffy, M. J. "Biochemical markers as prognostic indices in breast cancer". Clinical Chemistry 36, nr 2 (1.02.1990): 188–91. http://dx.doi.org/10.1093/clinchem/36.2.188.

Pełny tekst źródła

Streszczenie:

Abstract Traditional prognostic markers in breast cancer include histological variables such as tumor size, grade, and axillary node status. In recent years some new potential prognostic markers of a biochemical nature have been described: estradiol receptors, progesterone receptors, epidermal growth factor receptors, erbB-2 proto-oncogene, and certain proteolytic enzymes. None of these new markers excels axillary node status as a prognostic marker. Biochemical markers can, however, be evaluated with use of minimal surgery and may help distinguish the minority of aggressive axillary-node-negative breast cancers.

Style APA, Harvard, Vancouver, ISO itp.

18

Watts, Nelson B. "Clinical Utility of Biochemical Markers of Bone Remodeling". Clinical Chemistry 45, nr 8 (1.08.1999): 1359–68. http://dx.doi.org/10.1093/clinchem/45.8.1359.

Pełny tekst źródła

Streszczenie:

Abstract Remodeling is essential for bone health. It begins with resorption of old bone by osteoclasts, followed by the formation of new bone by osteoblasts. Remodeling is coupled (formation is linked to resorption). After middle age or perhaps beginning earlier, bone loss occurs because resorption exceeds formation. This imbalance is accentuated by estrogen deficiency as well as by many diseases and conditions. Biochemical markers that reflect remodeling and can be measured in blood or urine include resorption markers (e.g., collagen cross-links) and formation markers (e.g., alkaline phosphatase). Bone markers exhibit substantial short-term and long-term fluctuations related to time of day, phase of the menstrual cycle, and season of the year, as well as diet, exercise, and anything else that alters bone remodeling. These biological factors, in addition to assay imprecision, produce significant intra- and interindividual variability in markers. Bone marker measurements are noninvasive, inexpensive, and can be repeated often. Unfortunately, most of the studies that provided insight on clinical situations did not focus on markers as a primary endpoint. Bone markers have been useful in clinical practice and have been helpful in understanding the pathogenesis of osteoporosis and the mechanism of action of therapies. In clinical trials, markers aid in selecting optimal dose and in understanding the time course of onset and resolution of treatment effect. Clinical questions that might be answered by bone markers include diagnosing osteoporosis, identifying “fast bone losers” and patients at high risk of fracture, selecting the best treatment for osteoporosis, and providing an early indication of the response to treatment. Additional information is needed to define specific situations and cut points to allow marker results to be used with confidence in making decisions about individual patients.

Style APA, Harvard, Vancouver, ISO itp.

19

Cheung, K. L., S. E. Pinder, C. Paish, A. H. Sadozye, S. Y. Chan, A. J. Evans, R. W. Blamey i J. F. R. Robertson. "The Role of Blood Tumor Marker Measurement (Using a Biochemical Index Score and C-Erbb2) in Directing Chemotherapy in Metastatic Breast Cancer". International Journal of Biological Markers 15, nr 3 (lipiec 2000): 203–9. http://dx.doi.org/10.1177/172460080001500310.

Pełny tekst źródła

Streszczenie:

The role of blood tumor markers in monitoring response in advanced breast cancer is established in endocrine therapy and standard chemotherapy. This study examines marker levels in patients receiving new chemotherapy regimens. Thirty patients were recruited into two multicenter trials in which docetaxel-based regimens were used in 15 patients. The other 15 received doxorubicin-based regimens. Biochemical response calculated from a score using CA15.3, CEA and ESR was compared with UICC response. Marker changes at 2, 4 and 5 months correlated with UICC response at 3, 41/2 and 6 months, respectively (p < 0.03). Eleven patients achieved both clinical/radiological and biochemical response at the end of treatment; markers had not yet returned to below cutoffs in seven, suggesting a possible advantage to continue chemotherapy. No patient showed a biochemical response whilst judged clinically/radiologically progressive. Nineteen patients had progressed either clinically/radiologically or biochemically at six months; of these, eight showed progression assessed earlier by markers so that a median of four cycles of chemotherapy could have been saved. Measurements of serum c-erbB2 showed a correlation with tissue c-erbB2 staining in the primary tumor (p < 0.003). Among the patients with positive tissue staining, sequential changes in serum c-erbB2 completely paralleled initial response.

Style APA, Harvard, Vancouver, ISO itp.

20

Zaitseva, O. V. "Biochemical markers of bone collagen type I metabolism". Ukrainian Biochemical Journal 87, nr 1 (27.02.2015): 21–32. http://dx.doi.org/10.15407/ubj87.01.021.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Franco, Leonardo, i Mario Alejandro Ortíz Salazar. "Biochemical markers of bone metabolism". Revista Estomatología 18, nr 1 (28.09.2017): 30–34. http://dx.doi.org/10.25100/re.v18i1.5707.

Pełny tekst źródła

Streszczenie:

The quantity and quality of bone tissue renewal are dependent on the generation of new bone (deposition) mediated by osteoblasts and the loss (resorption) mediated by osteoclasts. For each of these processes there are important markers that can be measured in serum or urine. Resorption markers are products of metabolic degradation of bone matrix in particu-lar of the type I collagen (hydroxyproline, pyridinoline and deoxypyridinoline). In addition, the resorptive activity can also be evaluated through the tartrate resistant acid phosphatase (TRAP) and calcium-creatinine ratio in urine. Bone formation markers are collagen proteins (ALP, OCN), non collagen (ONC, OPN, BSP) or fragments of collagen synthesis (procollagen peptides).

Style APA, Harvard, Vancouver, ISO itp.

22

Rosen, Clifford J., i Alan Tenenhouse. "Biochemical markers of bone turnover". Postgraduate Medicine 104, nr 4 (październik 1998): 101–14. http://dx.doi.org/10.3810/pgm.1998.10.447.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Accomando, Salvatore. "Biochemical markers in Celiac disease". Frontiers in Bioscience S2, nr 1 (2010): 313–17. http://dx.doi.org/10.2741/s66.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Bapayeva, G. B. "Biochemical markers of premature birth". Journal of obstetrics and women's diseases 54, nr 3 (1.11.2005): 38–41. http://dx.doi.org/10.17816/jowd83449.

Pełny tekst źródła

Streszczenie:

Summary: In this article the results of the research of diagnostic importance of myoglobin determination in peripheral blood and amniotic fluid, fetal fibronectin examination in cervicovaginal composition contents of a pregnant woman are represented in prediction of premature birth.

Style APA, Harvard, Vancouver, ISO itp.

25

Koshul’ko, P. A., M. S. Kovalenko, Yu V. Abalenihina, A. I. Mirov, O. E. Golofast i E. D. Rokunov. "Biochemical markers of missed pregnancy". Problemy reproduktsii 27, nr 6 (2021): 138. http://dx.doi.org/10.17116/repro202127061138.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Lyubimova, N. V., i N. E. Kushlinskiy. "Biochemical markers of bone metastasis". Advances in molecular oncology 2, nr 1 (2.06.2015): 061. http://dx.doi.org/10.17650/2313-805x.2015.2.1.061-075.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Lyubimova, N. V., i N. E. Kushlinskiy. "Biochemical markers of bone metastasis". Advances in molecular oncology 2, nr 1 (2.06.2015): 061. http://dx.doi.org/10.17650/2313-805x.2015.2.1.61-75.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Kovářů, H., F. Kovářů, A. Fišerová, P. Zelníčková i E. Matalová. "Biochemical Markers of Lymphocyte Maturation". Acta Veterinaria Brno 71, nr 4 (2002): 503–8. http://dx.doi.org/10.2754/avb200271040503.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Delmas, Pierre D. "Biochemical markers of bone turnover". Acta Orthopaedica Scandinavica 66, sup266 (styczeń 1995): 176–82. http://dx.doi.org/10.3109/17453679509157687.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Griesmacher, A., P. Peichl, P. Pointinger, R. Mateau i H. Broll. "Biochemical markers in menopausal women". Scandinavian Journal of Clinical and Laboratory Investigation 57 (1997): 64–72. http://dx.doi.org/10.3109/00365519709168309.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Apple, Fred. "Biochemical markers of thrombolytic success". Scandinavian Journal of Clinical and Laboratory Investigation 59 (1999): 60–66. http://dx.doi.org/10.3109/00365519909168328.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Kemp, M., J. Donovan, H. Higham i J. Hooper. "Biochemical markers of myocardial injury". British Journal of Anaesthesia 93, nr 1 (lipiec 2004): 63–73. http://dx.doi.org/10.1093/bja/aeh148.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Kerrigan, Richard W., i Ian K. Ross. "Extracellular Laccases: Biochemical Markers forAgaricusSystematics". Mycologia 80, nr 5 (wrzesień 1988): 689–95. http://dx.doi.org/10.1080/00275514.1988.12025602.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Lyubimova, N. V., T. K. Churikova, M. G. Toms i N. E. Kushlinskiy. "BIOCHEMICAL MARKERS OF NEUROENDOCRINAL TUMORS". Tambov University Reports. Series: Natural and Technical Sciences 21, nr 2 (2016): 494–510. http://dx.doi.org/10.20310/1810-0198-2016-21-2-494-510.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Krstic, Danijela, Nenad Tomic, Branimir Radosavljevic, Natasa Avramovic, Vesna Dragutinovic, Sanja Radojevic Skodric i Mirjana Colovic. "Biochemical Markers of Renal Function". Current Medicinal Chemistry 23, nr 19 (19.07.2016): 2018–40. http://dx.doi.org/10.2174/0929867323666160115130241.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Demers, Laurence M., Luis Costa i Allan Lipton. "Biochemical Markers and Skeletal Metastases". Clinical Orthopaedics and Related Research 415 (październik 2003): S138—S147. http://dx.doi.org/10.1097/01.blo0000092979.12414.54.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Thompson, R. P. H. "Biochemical markers of liver disease". Current Opinion in Gastroenterology 1, nr 3 (maj 1985): 377–89. http://dx.doi.org/10.1097/00001574-198505000-00002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Matull, W. R. "Biochemical markers of acute pancreatitis". Journal of Clinical Pathology 59, nr 4 (1.04.2006): 340–44. http://dx.doi.org/10.1136/jcp.2002.002923.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Engler, H., B. Thürlimann i F. Riesen. "Biochemical Markers of Bone Remodelling". Oncology Research and Treatment 19, nr 2 (1996): 126–31. http://dx.doi.org/10.1159/000218778.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Griesmacher, A., P. Peichl, P. Pointinger, R. Mateau i H. Bröll. "Biochemical markers in menopausal women". Scandinavian Journal of Clinical and Laboratory Investigation 57, sup227 (styczeń 1997): 64–72. http://dx.doi.org/10.1080/00365519709168309.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Apple, Fred S. "Biochemical markers of thrombolytic success". Scandinavian Journal of Clinical and Laboratory Investigation 59, sup230 (styczeń 1999): 60–66. http://dx.doi.org/10.1080/00365519909168328.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Gao, F., i D. N. F. Harris. "Biochemical markers of cerebral damage". European Journal of Anaesthesiology 14, nr 2 (marzec 1997): 113–17. http://dx.doi.org/10.1097/00003643-199703000-00001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

De Jongh, R., C. De Deyne, G. Kenis, G. Vundelinckx, L. Merckx i R. Heylen. "Biochemical markers of brain ischaemia". European Journal of Anaesthesiology 15, Supplement 17 (styczeń 1998): 14–15. http://dx.doi.org/10.1097/00003643-199801001-00011.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Crofton, P. M., H. F. Stirling, E. Schönau, S. F. Ahmed, W. H. B. Wallace, J. C. Wade, R. Magowan i in. "Biochemical Markers of Bone Turnover". Hormone Research 45, nr 1 (1996): 55–58. http://dx.doi.org/10.1159/000184832.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Rambotti, Pietro. "Biochemical markers in lymphoproliferative diseases". Critical Reviews in Oncology/Hematology 2, nr 4 (styczeń 1985): 297–321. http://dx.doi.org/10.1016/s1040-8428(85)80006-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Shepherd, J. "Biochemical risk markers of CHD". Atherosclerosis 144 (maj 1999): 144. http://dx.doi.org/10.1016/s0021-9150(99)80558-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Seibel, Markus J. "Biochemical markers of bone remodeling". Endocrinology and Metabolism Clinics of North America 32, nr 1 (marzec 2003): 83–113. http://dx.doi.org/10.1016/s0889-8529(02)00077-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Garnero, Patrick, i Pierre D. Delmas. "BIOCHEMICAL MARKERS OF BONE TURNOVER". Endocrinology and Metabolism Clinics of North America 27, nr 2 (czerwiec 1998): 303–23. http://dx.doi.org/10.1016/s0889-8529(05)70007-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Gavaghan, Mary. "Biochemical Markers in Myocardial Injury". AORN Journal 70, nr 5 (listopad 1999): 839–54. http://dx.doi.org/10.1016/s0001-2092(06)61303-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Yuasa, Isao, i Kazuo Umetsu. "Molecular aspects of biochemical markers". Legal Medicine 7, nr 4 (lipiec 2005): 251–54. http://dx.doi.org/10.1016/j.legalmed.2004.12.001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!